Published in Environ Health Perspect on December 01, 1997
Assessment of dioxin-like soil contamination in Mexico by enzyme-linked immunosorbent assay. Arch Environ Contam Toxicol (2009) 0.77
An atypical cause of alkali chemical burn: a case report. Ann Burns Fire Disasters (2010) 0.75
Urinary 1-hydroxypyrene as a comprehensive carcinogenic biomarker of exposure to polycyclic aromatic hydrocarbons: a cross-sectional study of coke oven workers in China. Int Arch Occup Environ Health (2013) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol (1982) 6.48
Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit Rev Toxicol (1990) 5.18
Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment. Crit Rev Toxicol (1994) 4.59
Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol (1996) 3.01
Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Annu Rev Pharmacol Toxicol (1986) 2.36
Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab Dispos (1975) 2.21
Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Annu Rev Pharmacol Toxicol (1990) 1.69
Impact of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls on human and environmental health, with special emphasis on application of the toxic equivalency factor concept. Eur J Pharmacol (1992) 1.29
The cytosolic receptor binding affinities and AHH induction potencies of 29 polynuclear aromatic hydrocarbons. Toxicol Lett (1986) 1.07
Swedish dioxin survey: evaluation of the H-4-II E bioassay for screening environmental samples for dioxin-like enzyme induction. Pharmacol Toxicol (1991) 1.07
PCB isomers and congeners: induction of aryl hydrocarbon hydroxylase and ethoxyresorufin O-deethylase enzyme activities in rat hepatoma cells. Toxicol Lett (1982) 0.99
Environmental toxicology of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans. Environ Health Perspect (1993) 0.98
Induction of enzyme activity in cell culture: a rapid screen for detection of planar polychlorinated organic compounds. J Assoc Off Anal Chem (1979) 0.92
Sources of PCDD/PCDF and impact on the environment. Chemosphere (1996) 0.92
Assessment of biological activities of mixtures of polychlorinated dibenzo-p-dioxins: comparison between defined mixtures and their constituents. Arch Toxicol (1991) 0.90
Comparative potencies of Aroclors 1232, 1242, 1248, 1254, and 1260 in male Wistar rats--assessment of the toxic equivalency factor (TEF) approach for polychlorinated biphenyls (PCBs). Fundam Appl Toxicol (1993) 0.88
Synergistic activity of polynuclear aromatic hydrocarbon mixtures as aryl hydrocarbon (Ah) receptor agonists. Chem Biol Interact (1993) 0.88
Assessment of biological activities of mixtures of polychlorinated dibenzo-p-dioxins (PCDDs) and their constituents in human HepG2 cells. Arch Toxicol (1992) 0.88
Toxicokinetic interactions between chlorinated aromatic hydrocarbons in the liver of the C57BL/6J mouse: I. Polychlorinated biphenyls (PCBs). Arch Toxicol (1993) 0.86
Nonadditive interactive effects of polychlorinated biphenyl congeners in rats: role of the 2,3,7,8-tetrachlorodibenzo-p-dioxin receptor. Can J Physiol Pharmacol (1987) 0.84
Comparison of CYP1A1 induction and genotoxicity in vitro as indicators of potentially harmful effects of environmental samples. Arch Toxicol (1994) 0.82
Potency of mixtures of polychlorinated biphenyls as inducers of dioxin receptor-regulated CYP1A activity in rat hepatocytes and H4IIE cells. Toxicology (1995) 0.82
Assessment of renal dopaminergic system activity during cyclosporine A administration in the rat. Br J Pharmacol (1995) 0.80
Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect (1998) 6.08
[Metabolic products of microorganisms. 98. Phosphinothricin and phosphinothricyl-alanyl-analine]. Helv Chim Acta (1972) 2.99
The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics (1997) 2.55
Metabolic products of microorganisms. 224. Bafilomycins, a new group of macrolide antibiotics. Production, isolation, chemical structure and biological activity. J Antibiot (Tokyo) (1984) 1.75
Effects of phenobarbital and 3-methylcholanthrene on substrate specificity of rat liver microsomal UDP-glucuronyltransferase. Biochim Biophys Acta (1973) 1.59
UDP-glucuronyltransferase in perfused rat liver and in microsomes - III. Effects of galactosamine and carbon tetrachloride on the glucuronidation of 1-naphthol and bilirubin. Biochem Pharmacol (1976) 1.47
Stoffwechselprodukte von mikroorganismen. 154. Mitteilung. Nikkomycin, ein neuer hemmstoff der chitinsynthese bei pilzen. Arch Microbiol (1976) 1.37
The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence. DNA Cell Biol (1991) 1.35
Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction. Clin Pharmacol Ther (2000) 1.27
The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes. Pharmacogenetics (1994) 1.25
Localization and turnover studies of membrane nicotinamide adenine dinucleotide glycohydrolase in rat liver. J Biol Chem (1971) 1.19
Toxicity of green tea extracts and their constituents in rat hepatocytes in primary culture. Food Chem Toxicol (2005) 1.14
Increased coupling yields in solid phase peptide synthesis with a modified carbodiimide coupling procedure. Hoppe Seylers Z Physiol Chem (1972) 1.14
UDP-glucuronosyltransferase activities. Guidelines for consistent interim terminology and assay conditions. Biochem Pharmacol (1983) 1.14
Quantitative analysis of enzyme-altered liver foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol (1996) 1.12
Turnover of heme and protein moieties of rat liver microsomal cytochrome b5. Biochem Biophys Res Commun (1970) 1.11
Animal studies addressing the carcinogenicity of TCDD (or related compounds) with an emphasis on tumour promotion. Food Addit Contam (2000) 1.07
Separation and partial purification of two differentially inducible UDP-glucuronyltransferases from rat liver. Biochem Pharmacol (1977) 1.06
Regulation of -aminolevulinic acid synthetase by drugs and steroids in vivo and in isolated perfused rat liver. Eur J Biochem (1971) 1.05
The effect of rifampin treatment on intestinal expression of human MRP transporters. Am J Pathol (2000) 1.04
Conformational studies on murein-lipoprotein from the outer membrane of Escherichia coli. Eur J Biochem (1976) 1.04
Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution. J Hum Genet (2001) 1.02
UDP-glucuronyltransferase in perfused rat liver and in microsomes: influence of phenobarbital and 3-methylcholanthrene. Eur J Biochem (1974) 1.02
Purification of rat-liver microsomal UDP-glucuronyltransferase. Separation of two enzyme forms inducible by 3-methylcholanthrene or phenobarbital. Eur J Biochem (1979) 1.01
New developments in glucuronidation research: report of a workshop on "glucuronidation, its role in health and disease". Hepatology (1992) 0.99
Genomic alterations of the c-myc protooncogene in relation to the overexpression of c-erbB2 and Ki-67 in human breast and cervix carcinomas. J Cancer Res Clin Oncol (1991) 0.99
Differential induction of rat liver microsomal UDP-glucuronosyltransferase activites by various inducing agents. Biochem Pharmacol (1982) 0.97
Dioxins: WHO's tolerable daily intake (TDI) revisited. Chemosphere (2000) 0.97
Determination of microsomal UDP-glucuronyltransferase in needle-biopsy specimens of human liver. Eur J Clin Pharmacol (1978) 0.97
A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers. Eur J Clin Pharmacol (1998) 0.95
Paracetamol as a test drug to determine glucuronide formation in man. Effects of inducers and of smoking. Eur J Clin Pharmacol (1987) 0.95
Failure sequences in the solid phase synthesis of polypeptides. J Am Chem Soc (1970) 0.95
Malassezin--A novel agonist of the arylhydrocarbon receptor from the yeast Malassezia furfur. Bioorg Med Chem (2001) 0.95
[Identification of amino acid phenylthiohydantoins by mass spectrometry]. Z Naturforsch B (1970) 0.94
Inducing effects of dioxin-like polychlorinated biphenyls on CYP1A in the human hepatoblastoma cell line HepG2, the rat hepatoma cell line H4IIE, and rat primary hepatocytes: comparison of relative potencies. Toxicol Sci (2001) 0.93
Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells. Drug Metab Dispos (1999) 0.93
Metabolism of naphthalene to naphthalene dihydrodiol glucuronide in isolated hepatocytes and in liver microsomes. Biochem Pharmacol (1976) 0.92
[Studies on the structure of ferredoxin]. Eur J Biochem (1969) 0.92
Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofluorene, ultraviolet light, or transforming growth factor beta 1. Cancer Res (1996) 0.92
Human risk assessment and TEFs. Food Addit Contam (2000) 0.91
Metabiolic products of microorganisms. Tirandamycin B(author's transl). Arch Microbiol (1976) 0.91
Assessment of biological activities of mixtures of polychlorinated dibenzo-p-dioxins: comparison between defined mixtures and their constituents. Arch Toxicol (1991) 0.90
Regulation of delta-aminolevulinic acid synthetase by drugs and steroids in isolated perfused rat liver. Enzyme (1973) 0.90
Induction of cMrp/cMoat gene expression by cisplatin, 2-acetylaminofluorene, or cycloheximide in rat hepatocytes. Hepatology (1997) 0.89
Sequence analysis and functional characterization of the 5'-flanking region of the rat multidrug resistance protein 2 (mrp2) gene. Biochem Biophys Res Commun (1998) 0.89
Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction. Eur J Pharm Sci (2001) 0.88
The role of conjugation reactions in detoxication. Arch Toxicol (1987) 0.88
Assessment of biological activities of mixtures of polychlorinated dibenzo-p-dioxins (PCDDs) and their constituents in human HepG2 cells. Arch Toxicol (1992) 0.88
Input/output balance of estrogenic active compounds in a major municipal sewage plant in Germany. Chemosphere (2000) 0.88
Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour promotion in rat liver. Carcinogenesis (1995) 0.86
[Degradation and resynthesis of the active sites of plant ferredoxins]. Biochim Biophys Acta (1967) 0.86
Functional heterogeneity of UDP-glucuronyltransferase in rat tissues. Biochem Pharmacol (1980) 0.86
Ethnic variability in the allelic distribution of human aryl hydrocarbon receptor codon 554 and assessment of variant receptor function in vitro. Pharmacogenetics (2001) 0.86
UDP-glucuronyltransferase in perfused rat liver and in microsomes. Effects of CCl4 injury. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.86
Elimination kinetics and toxicity of 2,3,7,8-tetrachlorothianthren, a thio analogue of 2,3,7,8-TCDD. Chemosphere (1998) 0.85
Localization and regulation of two NAD nucleosidases in Ehrlich ascites cells. Eur J Biochem (1968) 0.85
Colocalization of three types of intermediate filament proteins in perisinusoidal stellate cells: glial fibrillary acidic protein as a new cellular marker. Eur J Cell Biol (1996) 0.85
Promotion of preneoplastic foci in rat liver with 2,3,7,8-tetrachlorodibenzo-p-dioxin, 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin and a defined mixture of 49 polychlorinated dibenzo-p-dioxins. Carcinogenesis (1994) 0.85
Phenolic xenoestrogens in surface water, sediments, and sewage sludge from Baden-Württemberg, south-west Germany. Environ Pollut (2001) 0.84
Metabolism of xenobiotics in hepatocyte nodules. Toxicol Pathol (1987) 0.84
Teratogenic potency of 2,3,4,7,8-pentachlorodibenzofuran and of three mixtures of polychlorinated dibenzo-p-dioxins and dibenzofurans in mice. Problems with risk assessment using TCDD toxic-equivalency factors. Arch Toxicol (1993) 0.83
2,3,7,8-Tetrachlorodibenzo-p-dioxin and ethinylestradiol as co-mitogens in cultured rat hepatocytes. Carcinogenesis (1992) 0.83
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-mediated membrane translocation of c-Src protein kinase in liver WB-F344 cells. Arch Toxicol (1999) 0.83
Normal pathways for glucuronidation, sulphation and oxidation of paracetamol in Gilbert's syndrome. Eur J Clin Invest (1987) 0.83
Dioxin-like PCBs in the environment-human exposure and the significance of sources. Chemosphere (1998) 0.83
Influence of fasting and hemin on microsomal cytochromes and enzymes. Biochem Pharmacol (1973) 0.83
Tissue-specific constitutive and inducible expression of rat phenol UDP-glucuronosyltransferase. Biochem Pharmacol (1994) 0.83
Abolition of the apparent deficiency of 2-aminophenol glucuronidation in perfused Gunn rat liver by pentan-3-one. Biochem Pharmacol (1980) 0.82
Glucuronidation of carcinogenic arylamines and their N-hydroxy derivatives by rat and human phenol UDP-glucuronosyltransferase of the UGT1 gene complex. Carcinogenesis (1994) 0.82
Immunochemical studies on rat-liver microsomal NAD glycohydrolase. Eur J Biochem (1973) 0.82
Development of a sensitive E-screen assay for quantitative analysis of estrogenic activity in municipal sewage plant effluents. Sci Total Environ (1999) 0.82
Histochemical and immunohistochemical detection of putative preneoplastic liver foci in women after long-term use of oral contraceptives. Virchows Arch B Cell Pathol Incl Mol Pathol (1986) 0.82
Potency of mixtures of polychlorinated biphenyls as inducers of dioxin receptor-regulated CYP1A activity in rat hepatocytes and H4IIE cells. Toxicology (1995) 0.82
Basal expression of the rat, but not of the human, multidrug resistance protein 2 (MRP2) gene is mediated by CBF/NF-Y and Sp1 promoter-binding sites. Toxicology (2001) 0.82
Increased uridine diphosphate-glucuronyltransferase activity in preneoplastic liver nodules and Morris hepatomas. Cancer Res (1982) 0.82
TCDD-inducible plasminogen activator inhibitor type 2 (PAI-2) in human hepatocytes, HepG2 and monocytic U937 cells. Carcinogenesis (1996) 0.82
Validation and application of a rapid in vitro assay for assessing the estrogenic potency of halogenated phenolic chemicals. Chemosphere (1999) 0.81
Influence of P-4502E1 induction on benzene metabolism in rat hepatocytes and on biliary metabolite excretion. Drug Metab Dispos (1992) 0.81
Potency of various polycyclic aromatic hydrocarbons as inducers of CYP1A1 in rat hepatocyte cultures. Chem Biol Interact (1999) 0.81
Metabolism of hexachloro-1,3-butadiene in mice: in vivo and in vitro evidence for activation by glutathione conjugation. Xenobiotica (1988) 0.80
N-glucuronide formation of carcinogenic aromatic amines in rat and human liver microsomes. Biochem Pharmacol (1984) 0.80
Proton magnetic resonance study of the histidine residues of sperm whale and horse myoglobins. J Mol Biol (1972) 0.80
Hepatic canalicular membrane 4: expression of the multidrug resistance genes in the liver. FASEB J (1997) 0.80
Paracetamol test: modification by renal function, urine flow and pH. Eur J Clin Pharmacol (1990) 0.80
UDP-glucuronyltransferase in perfused rat liver and in microsomes: V. Studies with Gunn rats. Biochem Pharmacol (1978) 0.80
UDP-glucuronyltransferase in perfused rat liver and in microsomes. Glucuronidation of bilirubin. Eur J Biochem (1976) 0.80
UDP glucuronyltransferase activity in isolated perfused rat liver. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.80
Glucuronidation and isomerization of all-trans- and 13-cis-retinoic acid by liver microsomes of phenobarbital- or 3-methylcholanthrene-treated rats. Biochem Pharmacol (1994) 0.80
Dual role of glucuronyl- and sulfotransferases converting xenobiotics into reactive or biologically inactive and easily excretable compounds. Arch Toxicol (1977) 0.80
Induction of cytochrome P4501A by smoking or omeprazole in comparison with UDP-glucuronosyltransferase in biopsies of human duodenal mucosa. Eur J Clin Pharmacol (1995) 0.79
Induction of hepatic mrp2 (cmrp/cmoat) gene expression in nonhuman primates treated with rifampicin or tamoxifen. Arch Toxicol (1998) 0.79
Induction of CYP1A and glutathione S-transferase activities by 2,3,7,8-tetrachlorodibenzo-p-dioxin in human hepatocyte cultures. Carcinogenesis (1995) 0.79